HHS Secretary nominee Robert F. Kennedy Jr. will divest his interests in several biopharma companies, including CRISPR ...

Don Dempsey reportedly in frame to serve as Office of Management and Budget’s leading health offical, a role that would hand him sweeping powers to rein in Kennedy’s ambitions ...

Thermo Fisher Scientific should be safe. RFK Jr. may disrupt Big Pharma, but he’s unlikely to cause research to completely ...

Trump 2.0 prioritizes AI and space, while infectious disease and climate research decline in South Koreas context Trump 2.0s ...

Following his win over Kamala Harris, Donald Trump has been assembling the administration for his second term in the White ...

At J.P. Morgan, most biopharma executives expressed a neutral stance on the incoming administration, but just days later, ...

In his inaugural address, President Donald Trump promised to reform the public health system and reverse actions taken ...

Just as quickly, investors are losing their appetite for the trade. After a disappointing trial of a new Novo Nordisk drug ...

Jon Hochschartner Anyone who cares about animals should oppose Robert F. Kennedy Jr., President-Elect Donald Trump’s nominee for secretary of Health and Human Services. Available evidence suggests he ...

This was the environment that created Al Capone. The first celebrity gangster, Capone was happy to be perceived as the head ...

President Donald Trump made good on his campaign promises to kick off his second term in office with a tidal wave of ...

EBR Systems is girding for US FDA approval of its novel heart lead in April and commercialisation by the end of the year.